I
NTLA//CIK 0001652130
Intellia Therapeutics, Inc.
Market Data
$13.82+$4.38 (+46.40%)
NTLA · Last trade
Prev Close
$9.44
Range (30d)
$8.99 – $15.90
Recent Filings
- 8-K189.2 KBIntellia Therapeutics, Inc.Jan 27, 8:19 AM ET·0001193125-26-023387
- 8-K5.1 MBIntellia Therapeutics, Inc.Jan 9, 8:07 AM ET·0001193125-26-008307
- 8-K238.9 KBIntellia Therapeutics, Inc.Nov 10, 5:24 PM ET·0001193125-25-274596
- 10-Q10.7 MBIntellia Therapeutics, Inc.Nov 6, 4:26 PM ET·0001193125-25-269680
- 8-K225.0 KBIntellia Therapeutics, Inc.Nov 6, 4:06 PM ET·0001193125-25-269479
- 8-K143.7 KBIntellia Therapeutics, Inc.Oct 29, 4:22 PM ET·0001193125-25-256378
- 8-K221.2 KBIntellia Therapeutics, Inc.Oct 27, 8:01 AM ET·0001193125-25-250757
- 8-K211.3 KBIntellia Therapeutics, Inc.Sep 25, 4:19 PM ET·0001193125-25-217484
- 10-Q10.6 MBIntellia Therapeutics, Inc.Aug 7, 4:06 PM ET·0000950170-25-104987
- 8-K405.7 KBIntellia Therapeutics, Inc.Aug 7, 7:45 AM ET·0000950170-25-104574
Insiders
10- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Baker Bros. Advisors (GP) LLC10% Owner
- BAKER BROS. ADVISORS LP10% Owner
- BAKER FELIX10% Owner
- BAKER JULIAN10% Owner
- BASTA JAMESEVP, General Counsel
- Bell GraemeEVP, Chief Financial Officer
- Bermingham NessanDirector, President & CEO, 10% Owner
Tickers
Addresses
business
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139
mailing
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139